Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2/3 1Phase 2 1

Status

Completed 5

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other 5CNS 1

Conditions

Polycystic Ovary Syndrome 6Obesity 5Sexual Infantilism 4Craniopharyngioma 3Overweight 2Weight Loss 1Insulin Resistance 1Fatty Liver 1Diabetes Mellitus, Type 1 1

Interventions

Exercise 24Metformin 23Resistance Training 8Nutrition Assessment 8Methods 8Tirzepatide 7Diet Therapy 7Diet 7Counseling 7Early Intervention, Educational 6Caloric Restriction 6Exenatide 5semaglutide 4Liraglutide 4Educational Status 4Docosahexaenoic Acids 4Diet, Mediterranean 4Vitamin D 3Therapeutics 3Surveys and Questionnaires 3Sugars 3Standard of Care 3Dexamethasone 3Yoga 2Tablets 2Specimen Handling 2Progestins 2Ovidrel 2Nutritional Status 2Naltrexone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Obesity × Exenatide × Clear all
NCT02157974 2024-06-04

APPLE

University of Colorado, Denver

Phase 2/3 Completed
92 enrolled 17 charts
Other

Fatty Liver, Obesity, Polycystic Ovary Syndrome

NCT02664441 2022-05-05

ECHO

Seattle Children's Hospital

Phase 3 Completed
42 enrolled 26 charts
Other

Obesity, Weight Loss, Sexual Infantilism

NCT02635386 2021-01-29

EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

Woman's

Phase 3 Completed
119 enrolled 34 charts
Other

Obesity, Polycystic Ovary Syndrome

NCT03352869 2019-09-11

Research of Exenatide for Overweight/Obese PCOS Patients With IGR

RenJi Hospital

Phase 4 Completed
183 enrolled
Other

Obesity, Polycystic Ovary Syndrome, Overweight

NCT01484873 2017-03-03

Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor

Vanderbilt University Medical Center

Phase 2 Completed
10 enrolled 15 charts
CNSOther

Craniopharyngioma, Obesity, Sexual Infantilism, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡